KellySchoenbeckMD

Hematologic Oncology

Physician

Dr. Schoenbeck is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 2021
University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 2017 - 2020
New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 2012 - 2015
Oregon Health and Science University School of MedicineClass of 2012, MD

PubMed

Abstracts/Posters

Cognitive Dysfunction Associated with Tyrosine Kinase Inhibitors in Patients with CML in Chronic Phase
Kelly L. Schoenbeck, MD, Sirisha Tummala, MD, Neha G. Goyal, PhD, Catherine C. Smith, MD and Neil P. Shah, MD, PhD, 62nd American Society of Hematology Annual Meeting & Exposition, 12/6/2020
Direct Oral Anticoagulant Use and Outcomes in Patients with High and Intermediate Risk BCR-ABL-Negative Myeloproliferative Neoplasms
Kelly L. Schoenbeck, MD , Giselle Salmasi, MD , Miguel Carlos Cerejo, DO , Patricia A. Cornett, MD , Lloyd E. Damon, MD , Aaron C. Logan, MD PhD , Rebecca L. Olin, MD ..., 61st American Society of Hematology Annual Meeting & Exposition, Orlando, FL, 12/7/2019

Clinical Challenges: Discontinuing TKIs in Chronic Myeloid LeukemiaDecember 11th, 2020
Program Chairs Pick Their Top ASH HighlightsDecember 1st, 2017